Skip to main content
. 2015 Jul 30;172(17):4291–4302. doi: 10.1111/bph.13199

Figure 5.

Figure 5

Effects of the 10 day treatment with CSA (20 mg·kg·1·day−1), Indo (5 mg·kg−1·day−1) or their combination on renal ET-1 and TGF-β1 in Sprague-Dawley rats. The effect of endothelin ETA receptor blockade by atrasentan (5 mg·kg−1·day−1) on the CSA–Indo combination is also shown. Values are means ± SEM of six observations. *P < 0.05 versus vehicle; +P < 0.05 versus CSA; #P < 0.05 versus Indo-5; $P < 0.05 versus CSA/Indo-5.